Shandong Sito Bio-technology Co Ltd

300583

Company Profile

  • Business description

    Shandong Sito Bio-technology Co Ltd is a biotechnology company. It uses genetic engineering technology and microbial transformation technology to develop and produce steroid drug raw materials, specialty respiratory raw materials and finished preparations, and other drug intermediaries. The company operates in the following business segments; intermediates, high-end specialty respiratory APIs, and preparations. Its product offerings include androstenedione (AD), 9-hydroxy androstenedione (90H-AD), 17a-hydroxyprogesterone derivatives (A ring), and bi-decanoic acid (BA), and others. In addition, the company holds patents for various APIs and other intermediaries.

  • Contact

    South Section of East Outer Ring Road
    Dingtao District
    Shandong Province
    Heze274100
    CHN

    T: +86 5302263536

    http://www.sitobiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    959

Stocks News & Analysis

stocks

This ASX miner is the cheapest in our iron ore coverage

High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks

Apple names new CEO as Tim Cook steps aside after 15 years

John Ternus, Apple’s hardware chief, will take up the role in September.
stocks

Updating our commodity price assumptions

Our view as China’s steel production drops.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,074.4050.80-0.56%
CAC 408,156.4379.28-0.96%
DAX 4024,194.9075.97-0.31%
Dow JONES (US)49,490.03340.650.69%
FTSE 10010,476.4621.63-0.21%
HKSE26,163.24324.24-1.22%
NASDAQ24,657.57397.601.64%
Nikkei 22559,585.86236.690.40%
NZX 50 Index12,945.6013.270.10%
S&P 5007,137.9073.891.05%
S&P/ASX 2008,843.6053.20-0.60%
SSE Composite Index4,106.2621.180.52%

Market Movers